NL-OMON21690招募中不适用
Quantitative sensory testing and intraepidermal nerve fiber density for improved diagnosis of Fabry disease.
TIpharma consortiumAcademia: Amcpharma: Genzyme, a sanofy companysubsidizing party: Shire HGT0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Decrease in alpha-galactosidase A activity in leucocytes, plasma or fibroblasts
- •according to local laboratory criteria AND presence of a mutation in the alpha-
- •galactosidase A gene of uncertain clinical relevance.
排除标准
- •Patient is unwilling to participate.
研究者
相似试验
已完成
不适用
Quantitative sensory testing and intraepidermal nerve fibre density for improved diagnosis of Fabry disease.Anderson-Fabry disease10027424Fabry diseaseNL-OMON37662Academisch Medisch Centrum30
已完成
不适用
Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol ConcentrationThe Sweat Alcohol ConcentrationNCT02860195Assistance Publique Hopitaux De Marseille6
已完成
不适用
*Characteristics of Quantitative Sensory Testing in ACNES patients compared to healthy controls; a pilot study.*abdominal wall painentrapment neuropathy10034606NL-OMON43275Maxima Medisch Centrum40
招募中
不适用
Validation study of a new quantitative sensory testing device "intercross-220"JPRN-UMIN000045701Others30
招募中
不适用
The role of sensory parameters in predicting clinical outcome after lumbar discectomyNeurological - Other neurological disordersumbar radiculopathy with radicular painLumbar radiculopathy with radicular painSurgery - Other surgeryACTRN12614001070628Dr Brigitte Tampin160